- IN₹502.06bn
- IN₹470.57bn
- IN₹64.31bn
Brief: Gland Pharma Says US FDA Concludes Surprise Inspection At Dundigal Facility
Brief: Gland Pharma Gets Tentative Approval From U.S. FDA For Latanoprostene Bunod Ophthalmic Solution
Brief: Shanghai Fosun Pharma's Unit Sells 6.0% Stake In Gland Pharma
India's Gland Pharma down on reports Fosun to pare 5% stake in co
Brief: Fosun Is Said To Plan Block Deals To Pare 6% Stake In Gland Pharma - Bloomberg News
Brief: Gland Pharma Appoints Srinivas Sadu As CEO
India's Gland Pharma gains as USFDA inspection at facility ends
India's Gland Pharma up after Q4 rev beats estimates
India's Gland Pharma misses Q4 profit view on higher employee costs
Brief: Gland Pharma Receives US FDA Approval For Edaravone Injection
Brief: Gland Pharma Receives Approval For Plerixafor For Injection
KKR to buy India's Healthium Medtech at $839 mln valuation, sources say
KKR to buy India's Healthium Medtech at $839 mln valuation, sources say
Brief: Gland Pharma Gets US FDA Approval For Cetrorelix Acetate For Injection
India's Gland Pharma down in heavy trade on block deals
India's Gland Pharma sees best day in 2 months on US FDA approval for cancer drug
India's Gland Pharma rises as Motilal Oswal bullish on growth prospects
Indian auto, pharma stocks power shares up for fourth straight day
India's Gland Pharma posts Q3 profit fall on soaring employee costs